Bruce Campbell

Title: Bruce Campbell - Innovator in Apixaban Dosing

Introduction

Bruce Campbell is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of medicine, particularly in the area of thrombosis treatment. His innovative approach to Apixaban dosing has the potential to improve patient outcomes significantly.

Latest Patents

Bruce Campbell holds a patent for a method of administering a dosage of Apixaban to patients for the treatment or prevention of thrombosis. This method involves receiving patient data, including a kidney function metric, and processing this data with a dosage calculator. The calculator is derived from a plasma level prediction model that predicts Apixaban drug plasma levels. The dosage is determined based on the patient's kidney function metric, ensuring a tailored approach to treatment. He has 1 patent in this area.

Career Highlights

Throughout his career, Bruce has focused on developing innovative medical solutions that address critical health issues. His work at Closed Loop Medicine Ltd. exemplifies his commitment to advancing medical technology and improving patient care.

Collaborations

Bruce collaborates with talented professionals in his field, including Paul Goldsmith and Michael Catt. These partnerships enhance the development and implementation of his innovative ideas.

Conclusion

In summary, Bruce Campbell is a pioneering inventor whose work in Apixaban dosing represents a significant advancement in thrombosis treatment. His innovative methods and collaborations continue to shape the future of medical care.